source
- Substance-use disorder biotech Tempero Bio shuts down after serious safety incidentTempero Bio, a biotech focused on treatments for substance use disorders, announced it will cease operations. The decision follows a serious adverse event that occurred during the company's develo…
- Post-Hoc Live: MAHA, the new Trump CDC pick and RFK's vaccine agendaMAHA’s sway over HHS could face a fresh test now that President Trump has a new pick for CDC director: Erica Schwartz, a former deputy surgeon general. The position has been empty ...Endpoints · 4mo ago↗ source
- Novartis' radioligand therapy Lutathera could soon face generic competition